Showing results (2451-2460 of 25,889) with videos related to

Sort By:
Pageof 2,589
Anticancer Research|May 6, 2009
ROS and innate immunityChie Kohchi, Hiroyuki Inagawa, Takashi Nishizawa, et al.
Anticancer Research|May 6, 2009
Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancerQun Huo, Tetsushi Kinugasa, Lin Wang, et al.
Anticancer Research|May 6, 2009
The role of toll-like receptor 2 in survival strategies of Mycobacterium tuberculosis in macrophage phagosomesAya Yoshida, Hiroyuki Inagawa, Chie Kohchi, et al.
Anticancer Research|May 6, 2009
Infliximab treatment for anal fistula in patients with Crohn's diseaseDaijiro Higashi, Kitaro Futami, Yuji Egawa, et al.
Anticancer Research|May 6, 2009
Cell growth stimulation by CRASH, an asparaginase-like protein overexpressed in human tumors and metastatic breast cancersUlrich H Weidle, Vesna Evtimova, Saverio Alberti, et al.
Anticancer Research|May 6, 2009
Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cellsYing Sun, Ehrentraud J Eichelbaum, William P Skelton, et al.
Anticancer Research|May 6, 2009
RUNX1 translocations in malignant hemopathiesEtienne De Braekeleer, Claude Férec, Marc De Braekeleer
Anticancer Research|May 6, 2009
Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergyBjørn T Moe, Anne B Vereide, Anne Orbo, et al.
Anticancer Research|May 6, 2009
Pharmacological interplay between breast cancer resistance protein and gefitinib in epidermal growth factor receptor signalingKazuhiro Katayama, Kazuhiko Shibata, Junko Mitsuhashi, et al.
Anticancer Research|May 6, 2009
EGFR mutation up-regulates EGR1 expression through the ERK pathwayMari Maegawa, Tokuzo Arao, Hideyuki Yokote, et al.
Pageof 2,589